Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.56%53.07B | -1.94%48.89B | 1.04%11.74B | -2.64%12.9B | -5.76%12.46B | 0.19%11.78B | 10.16%49.85B | 3.15%11.62B | 7.76%13.25B | 17.91%13.23B |
| Cost of revenue | 6.41%41.96B | -2.62%39.43B | -1.78%9.7B | -2.52%10.03B | -5.57%9.79B | -0.49%9.91B | 5.53%40.49B | 3.61%9.87B | 2.69%10.29B | 8.82%10.37B |
| Gross profit | 17.54%11.11B | 0.98%9.45B | 16.98%2.04B | -3.05%2.87B | -6.46%2.67B | 3.91%1.87B | 35.97%9.36B | 0.63%1.75B | 30.13%2.96B | 69.34%2.85B |
| Operating expense | 6.13%8.4B | 8.48%7.92B | 6.63%2.03B | 8.19%1.96B | 7.83%2B | 11.53%1.93B | 7.66%7.3B | 12.11%1.9B | -1.35%1.81B | 18.93%1.85B |
| Operating profit | 76.46%2.71B | -25.58%1.53B | 110.43%16.1M | -20.82%907.19M | -32.96%670.71M | -187.96%-60.56M | 1,877.58%2.06B | -486.23%-154.46M | 162.47%1.15B | 689.64%1B |
| Net non-operating interest income (expenses) | -3.64%-286.83M | -5.81%-276.76M | -18.81%-71.72M | -0.30%-68.13M | 0.11%-67.49M | -5.65%-69.42M | 8.34%-261.56M | 15.98%-60.36M | 10.52%-67.93M | 10.41%-67.57M |
| Non-operating interest income | 2,299.72%8.69M | -84.30%362K | -89.80%230K | 336.36%26K | 33.90%79K | 800.00%27K | 2,182.18%2.31M | 4,695.74%2.25M | 99.48%-11K | -97.26%59K |
| Non-operating interest expense | 6.64%295.52M | 5.02%277.12M | 14.90%71.95M | 0.36%68.16M | -0.08%67.57M | 5.69%69.45M | -7.56%263.87M | -12.90%62.62M | -7.98%67.92M | -12.83%67.63M |
| Net investment income | 33.16%525.32M | 10.95%394.5M | 1.54%8.71M | 13.09%179.06M | 26.56%25.49M | 7.55%181.23M | 16.10%355.56M | 0.70%8.58M | 17.31%158.33M | -20.92%20.14M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 1,751.00%5.76M | -100.85%-349K | 1.06M | -218.74%-1.34M | 0 | 98.12%-70K | 504.40%41.23M | 0 | 365.29%1.13M | 16,886.05%43.82M |
| Income from associates and other participating interests | -75.03%28.54M | 791.50%114.31M | 1,433.64%96.78M | -9.11%9.99M | -84.95%306K | 2.48%7.23M | -60.04%12.82M | 82.26%-7.26M | -79.08%10.99M | -88.00%2.03M |
| Special income (charges) | -84.26%110.3M | 179.68%700.64M | 375.62%508.39M | 244.28%151.09M | 29.01%29.44M | -84.77%11.71M | 21.01%250.52M | 3.00%106.89M | 45.74%43.89M | -43.83%22.82M |
| Less:Restructuring and mergern&acquisition | 5.76%-35.91M | 0.00%-38.1M | 0.00%-9.53M | -0.05%-9.53M | 0.02%-9.53M | 0.03%-9.53M | 53.01%-38.1M | 53.01%-9.53M | 53.04%-9.52M | 53.00%-9.53M |
| Less:Other special charges | 88.77%-74.96M | -213.21%-667.29M | -413.89%-503.61M | -311.93%-141.57M | -49.82%-19.92M | 96.75%-2.19M | -68.30%-213.05M | -16.44%-98M | -249.26%-34.37M | 34.70%-13.3M |
| Less:Write off | -88.17%562K | 646.70%4.75M | ---- | ---- | ---- | ---- | -3.64%636K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 6.94%255.69M | 11.82%239.09M | -25.61%72.29M | 175.58%26.49M | -25.73%61.2M | 14.21%79.12M | -42.59%213.81M | -20.19%97.17M | -138.28%-35.04M | 8.73%82.4M |
| Income before tax | 23.65%3.34B | 1.19%2.7B | 6,794.35%631.61M | -4.20%1.2B | -34.82%719.65M | -53.53%149.25M | 267.95%2.67B | -105.68%-9.44M | 87.63%1.26B | 424.87%1.1B |
| Income tax | 25.47%1.01B | 25.09%804.52M | 295.69%228.02M | -5.06%323.55M | -33.53%162.05M | -48.07%90.9M | 19.85%643.12M | -153.40%-116.52M | 131.42%340.79M | 228.82%243.79M |
| Net income | 22.89%2.34B | -6.38%1.9B | 276.90%403.6M | -3.88%880.81M | -35.18%557.6M | -60.07%58.34M | 969.25%2.03B | 305.90%107.08M | 75.29%916.34M | 531.58%860.28M |
| Net income continuous operations | 22.89%2.34B | -6.38%1.9B | 276.90%403.6M | -3.88%880.81M | -35.18%557.6M | -60.07%58.34M | 969.25%2.03B | 305.90%107.08M | 75.29%916.34M | 531.58%860.28M |
| Noncontrolling interests | 41.87%321.57M | 16.81%226.67M | 44.44%50.93M | 26.05%86.41M | -5.54%64.47M | 13.08%24.85M | 96.15%194.04M | 34.98%35.26M | 7.91%68.55M | 23.85%68.25M |
| Net income attributable to the company | 20.31%2.01B | -8.83%1.67B | 391.03%352.66M | -6.30%794.4M | -37.74%493.13M | -73.02%33.49M | 1,919.36%1.84B | 191.92%71.82M | 84.61%847.79M | 876.57%792.03M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 20.31%2.01B | -8.83%1.67B | 391.03%352.66M | -6.30%794.4M | -37.74%493.13M | -73.02%33.49M | 1,919.36%1.84B | 191.92%71.82M | 84.61%847.79M | 876.57%792.03M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 21.19%159.83 | -8.63%131.88 | 398.75%27.83 | -6.03%62.6 | -37.74%38.82 | -73.11%2.63 | 1,912.97%144.33 | 190.44%5.58 | 83.83%66.62 | 871.18%62.35 |
| Diluted earnings per share | 21.19%159.83 | -8.63%131.88 | 398.69%27.827 | -6.03%62.6 | -37.74%38.82 | -73.11%2.63 | 1,912.97%144.33 | 190.44%5.58 | 83.83%66.62 | 873.60%62.35 |
| Dividend per share | 108.33%25 | 20.00%12 | 20.00%12 | 0 | 0 | 0 | 66.67%10 | 66.67%10 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |